SEC Form 4 · accession 0001209191-18-062111
Tempest Therapeutics, Inc. · TPST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Carol Giltner Gallagher
Director
Period of report
Dec 7, 2018
Accepted (ET)
Dec 11, 2018 · 7:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001544227
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 7, 2018 | A | 8,249 | — | A | 8,249 | D | |
| Common StockF2 | Dec 7, 2018 | A | 23,684 | — | A | 23,684 | I | By: Gallagher Revocable Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Received in exchange for 110,887 shares of Millendo Therapeutics, Inc. common stock in connection with merger of Millendo Therapeutics, Inc. into the Issuer.
- F2Received in exchange for 318,335 shares of Millendo Therapeutics, Inc. common stock in connection with merger of Millendo Therapeutics, Inc. into the Issuer.